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Introduction
Since the identification of trigger activity in the pulmonary vein 
by Haissaguerre et al,2 catheter ablation of atrial fibrillation (AF) 
has became an established therapeutic modality for the treatment of 
patients with AF. Published data in the literature suggest that success 
rates following ablation of AF are relatively favorable (50-70%)3,4,5 
but most studies have reported limited follow-up of 1 or 2 years after 
the first ablation and the long-term outcomes have not been fully 
elucidated. 
Why do we need more information regarding the long term follow 
up data following AF ablation, in contrast with conventional ablation 
procedures?
First, the clinical significance of an AF recurrence is usually more 
pronounced than other arrhythmias because of the well known 
deleterious consequences of this arrhythmia, with special attention 
to thromboembolic complications. 
Furthermore, the pathologic mechanism of AF is complex with a 
special interplay between the triggering structures and a continuously 
evolving left atrial substrate. Consequently, it is important to analyze 
the long term response and define the durability of different ablation 
techniques to achieve a better clinical outcome.
Pulmonary vein isolation (PVI) is the mainstay therapy of 
paroxysmal AF, but its success is suboptimal in the persistent 
population.5,6 Additional ablation techniques have been introduced 
during the last decade.5 The AF population is very heterogeneous, with 
respect to duration and type of arrhythmia, comorbidities etc. On top 
of that, ablation results may depend on different definition of success, 
and follow up methods. Consequently, a comprehensive discussion of 
long term outcome of catheter ablation should include parameters 
like type of AF, ablation strategies, the use of antiarrhythmic drugs 
after ablation, multiple procedures, success definitions, the frequency 
and intensity of arrhythmia monitoring. The aim of the current study 
is to review the literature and evaluate the very long term success of 
catheter ablation of AF.
Definition Of Long Term Follow Up 
In the 2012 Expert Consensus on catheter ablation of atrial 
fibrillation,7 late recurrence of AF is defined as a recurrence after 
12 months or more after AF ablation and the long term success is 
defined as freedom from AF following the 3 months blanking period 
through a minimum of 36 months There is also consensus that all 
patients who undergo catheter ablation of AF should be controlled 
every six months for at least two years. In our review, we defined 
very long term follow up to be longer than 3 years after the index 
procedure
Impact Of  Type Of AF 
Depending on whether patients have paroxysmal (PAF), persistent, 
or longstanding persistent AF, the outcome of ablation procedures 
differs considerably. A systematic review and meta-analysis 
including17, mostly retrospective studies published by Ganesan et 
al8  demonstrated that the single procedure success for PAF was 68.6 
% at 1 year, 61.1% at 3 years and 62.3% at 5 years. After multiple 
procedures (average 1.45 procedure per patient) 79% of patients were 
free from AF at 5 years follow-up. Comparing patients with persistent 
and long-standing persistent AF after a single procedure the results 
were less favorable, 50.8% at 1 year, and 41.6% at 3 years. After 
multiple procedures, the success was definitely more promising in this 
population, 77.8 % in the long term, but only few studies reported 
the outcome of AF ablation after more than 3 years suggesting that 
we need more data to definitively assess the very long term efficacy 
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of ablation in persistent atrial fibrillation. The authors concluded that 
both single and multiple procedure success rates showed adequate 
stability over 3 years with a significant residual risk for a recurrence 
and the paroxysmal cohort demonstrated a superior single procedure 
efficacy. Tzou et al9 reported an AF freedom, off AAD, of 85% at 3 
years and 71% at 5 years, with a 7% per year late recurrence after the 
first ablation in a mixed paroxysmal and persistent AF population. In 
a multivariate analysis, persistent AF was an independent predictor 
for recurrence. 
Recently, Steinberg et al.10 published a large prospective cohort 
of AF population (72% paroxysmal, 28 % persistent) and followed 
445 patients for even a decade after a 1 year complete success 
following PVI. During a 62 months median follow up, 22 % of 
patients developed very late arrhythmia recurrence, and the authors 
demonstrated that the slope of the recurrence curve declined linearly. 
When they analyzed the differences in outcome on the basis of the 
arrhythmia pattern before the index ablation procedure, the results 
were strikingly different. The recurrence rates at 2, 5, an 10 years 
were 3%, 11%, and 27 % vs 13%, 29%, and 62% for paroxysmal 
and persistent AF patients, respectively (P< .0001). The authors 
concluded that the majority of AF patients did quite well over the 
time, and the ablation results are sustainable even for the long term 
as well, but using multivariate analysis, persistent AF (hazard ratio 
3.08; P< .0001) was an independent risk factor for recurrence of AF.
An interesting question concerning the long term recurrence 
and efficacy of the ablation procedure whether these interventions 
can prevent progression of the arrhythmia from paroxysmal to 
persistent form. In the study of Takigawa et al3 during a median 
follow up of approximately 48 months, AF progressed from 
paroxysmal to persistent in 1.2 % of patients in accordance with 
previous investigations where the AF progression rate was similar 
(1.5% -3%).11,12 In contrast, the results of pharmacologic therapy 
are definitely worse, the reported rates vary between 5.5% and 15%/
year.13,14 These observations suggest that the interventional therapy 
is better than drugs alone for preventing AF progression, which is 
an important aspect of long term consequences of the arrhythmia.
Impact of Ablation Techniques
Whereas a consensus has been reached on the suitable approach for 
ablation of patients with paroxysmal AF,7 no such consensus exists 
for patients with persistent and long lasting persistent AF regarding 
the optimal technology of treatment. 
Numerous clinical trials demonstrated that the main mechanism 
of AF recurrence after PVI in the paroxysmal population is the 
resumption of electrical conduction between the veins and left atrial 
muscle.  This statement is true for either the short or the long term 
recurrences (see below).8,15 Based upon these observations we should 
assume that at least in PAF, the durability of venous isolation and 
therefore permanent electrical disconnection plays a crucial role in 
maintaining procedural effectiveness in the long term. Accordingly, 
any kind of procedural tool or technique which can facilitate the 
durable isolation of pulmonary veins can be useful.
Segmental PV ablation or wider continuous circumferential 
antral ablation, two different procedures which have been used most 
commonly in clinical practice showed different outcomes. Sawhney 
et al16 reported that 86% of the patients were free from AF at 1 
year follow up after segmental pulmonary vein isolation, with 79%, 
and 56% free at 2 and 5 years respectively. A meta-analysis done by 
Proietti at al17 including 12 studies that compared the effectiveness 
of wide antral versus segmental pulmonary vein isolation concluded 
that PVI performed with a wide antral approach is more effective 
than ostial PVI in achieving freedom from atrial tachyarrhythmia 
recurrence at long-term follow-up (OR, 0.33; 95% CI, 0.24-0.46; P< 
.00001). They excluded the studies in which electric isolation was not 
assessed or if different catheter technologies were used. Ganesan et 
al8 also investigated if there is a statistical difference in outcomes of 
segmental PV isolation compared with wide antral circumferential 
ablation. The conclusion here was no, but they included also the 
studies with wide circumferential ablation without assessing the 
isolation of the pulmonary veins. 
An alternative energy source that has been developed to overcome 
some of the disadvantages of radiofrequency ablation is cryoenergy 
using a balloon based technology. A comparison (1:1 propensity score 
match) between cryoballoon and radiofrequency ablation showed 
similar long term success rates with a recurrence rate of 45 % in 
both groups after a two-year follow-up.18  Neumann et al19 reported 
freedom from AF in 74% of patients with paroxysmal AF and 42% 
with persistent AF, but the follow up time was shorter. Cryoablation 
is a new technology and it is under continuous development, but 
whether it can improve very long term outcomes has to be investigated 
in the future.
As mentioned earlier, in patients with persistent and longstanding 
persistent AF the data concerning the outcomes are considerably less 
favorable than for PAF. The wide contrast in PVI success rates between 
paroxysmal and persistent AF suggested that the mechanisms can be 
substantially different, and probably related to electrophysiological 
and structural remodeling of left atrial substrate. Not surprisingly, 
Figure 1:
Antral isolation of the left and right pulmonary veins guided by 
intracardiac echocardiography. Panel A: Lasso catheter was placed 
in the left common ostium between the left inferior and superior 
pulmonary vein (white arrow). Panel B: Ablation catheter (white 
arrow) is touching the right venous carina next to the right inferior 
pulmonary vein. LSPV: left superior pulmonary vein, LIPV: left 
inferior pulmonary vein, RIPV: right inferior pulmonary vein, Sept: 
interatrial septum. Images are originating from the database of 
Szeged University.
Figure 2:
Kaplan-Meier curve representing the arrhythmia free survival after 
single ablation procedure (Panel A) and following multiple ablation 
procedures (Panel B) in patients with paroxysmal (solid lines) vs 
persistent atrial fibrillation (broken lines). Data are originating from 
the database of Szeged University
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current approaches designed to target persistent AF are mainly 
based on modification of the atrial substrate, but exhibit remarkable 
differences, and a widely accepted uniform strategy is missing. 
Different ablation strategies, including the ablation of complex 
fractionated atrial electrograms (CFAEs),20 linear lesions in the left 
atrium,21 ablation at the maximal high dominant frequency spots,22 
rotor ablation23 have been developed as an add-on to pulmonary 
vein isolation to improve the outcome in this group. PVI alone can 
be sufficient to maintain sinus rhythm in 21% of patients after a 
single procedure and in 43.2% after 1-3 procedures in a retrospective 
analysis.6 The same 21-22% success with a single procedure and 37-
43% success rate after repeat procedures was published by Brooks 
at al5 in a review of 32 studies. They also reported the success rate 
of other techniques: linear ablation in addition to PVI (11-74%), 
posterior wall isolation (42-50%) CFAE ablation (36-68%) or 
“stepwise” ablation approach (38-62%). The integration of repeat 
procedures and addition of previously ineffective antiarrhythmic 
drugs further improved clinical success. The variation in the success 
rate suggests that the best approach in this group is still unclear. 
However, persistent and long-standing persistent AF can be treated 
with a relatively high success rate during rather a medium term 
follow up, since really long term data are still lacking. 
Our approach is wide area antral circumferential ablation 
for paroxysmal and persistent patients as well, with complete 
isolation of pulmonary veins, without creating additional lesions 
in the left atrium. During the procedures we use open irrigation 
radiofrequency catheters and a combination of EAM and intracardiac 
echocardiography (Figure 1) to enhance the anatomical orientation 
and the monitoring of catheter-tissue contact. After a mean of 18 
months follow up time the recurrence rate after single procedure 
was 52% and 61%, after multiple procedures was 19% and 29%, in a 
paroxysmal and persistent cohort respectively (Figure 2). 
Impact of Follow up Techniques
Apart from the above mentioned factors, the varying results 
reported by those studies could be attributed to substantial 
differences in follow up methods. During the first year, the majority 
of studies performed clinical examination, electrocardiogram and 24-
hour Holter monitoring or event recorders at 3, 6, and 12 months. 
Beyond the first year, the intensity of follow up is usually reduced to 
1 or 2 outpatient visits per year or even based on data from referring 
clinicians.24 There is a clear positive correlation between the duration 
and intensity of the follow-up and the arrhythmia detection rate.25 
For the short term follow up, 7 day Holter and transtelephonic 
monitoring are proven to be effective to detect asymptomatic AF 
episodes. Piorkowski et al.25 showed that using serial 7 day Holter 
and transtelephonic monitoring, the „real” procedural success rate 
decreased from 70%  to 50% and 45 % respectively.
The definition of long term ablation success remains controversial 
because current post ablation rhythm monitoring strategies are 
based on symptom and/or intermittent ECG recordings and thus 
probably underestimate the real rate of AF recurrences.26 Continuous 
monitoring like implantable loop recorders are useful tools27 but to 
put these devices into an everyday practice is limited by cost, patients 
compliance and high burden of false detection.
Predictors And Mechanism Of Recurrence
As we suggested earlier, the success of catheter ablation may 
depend on technical aspects of the procedure but also on patient 
related factors. Patients in whom AF recurred, exhibit specific clinical 
characteristics which can be considered as independent predictors of 
late AF recurrence. Some studies reported history of persistent AF 
as a predictor of very late recurrence8,9,10  while other studies found 
that there was no significant association between the AF type and 
risk of recurrence.15,28 The heterogeneity in results across the studies 
can be explained by the heterogeneous definition of AF type and 
the differences in terminology pertaining to “long term” follow up. 
The duration of AF history is a very important predictor of AF 
recurrence,3 but other studies could not find a significant association 
between AF duration and AF recurrence.29,30 A possible explanation 
is that duration of AF does not necessarily correlate with the length of 
the AF episodes and may not reflect the extent of atrial remodeling.31 
Other commonly identified predictors of AF recurrence are age > 
65 years, left atrial diameter >24mm/m²,31 left ventricular systolic 
dysfunction, heart failure, structural or valvular heart disease,8 
hypertension and hyperlipidemia.15 These observations indicate the 
role of enhanced vulnerability of left atrial myocardium induced 
by these factors beyond the importance of trigger mechanism. 
Aggressive medical treatment of these conditions and risk factors 
reduction32  may improve the efficacy of AF ablation. Pathak et 
al32 reported in a recent publication that risk factor management 
according to American Heart Association/American College of 
Cardiology guidelines significantly improved the outcome of AF 
ablation in terms of AF burden and also generated favorable changes 
in cardiac remodeling. 
The main mechanism of the early recurrence following atrial 
fibrillation ablation is the reconnection of previously isolated 
pulmonary veins. In contrast, in patients with very late recurrence 
the mechanism is not completely elucidated. Lin et al33 found that 
the majority of patients with recurrent AF undergoing a 3rd or more 
procedure after a mean follow up of 36±22 months (range 12 to 119 
months) had reconnected pulmonary veins with triggers originating 
from the culprit PVs. (Figure 3). However, in 20% of patients, new 
non-PV triggers were identified at the time of 3rd or 4th procedure 
Figure 3:
Late reconnection of the right inferior pulmonary veins in a 56 
years old patient with PAF following 32 months the index PVI. 
Single ablation attempt at the level of earliest PV potentials on 
Lasso,4-5 bipoles (arrow) resulted immediate isolation of the vein. 
All of the other pulmonary veins were isolated.
 Surface ECG leads I, II, V1 and V6, together with intracardiac 
recordings from the Lasso catheter (Lasso) placed in the right 
inferior pulmonary vein, and from the proximal to distal coronary 
sinus bipoles (CS). Tracing is originating from the database of 
Szeged University.
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Feb;22(2):137-41. 
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Registry of Atrial Fibrillation. Am Heart J. 2005 Mar;149(3):489-96.
14. de Vos CB, Pisters R, Nieuwlaat R, Prins MH, Tieleman RG, Coelen RJ, van den 
Heijkant AC, Allessie MA, Crijns HJ. Progression from paroxysmal to persistent 
atrial fibrillation clinical correlates and prognosis. J Am Coll Cardiol. 2010 Feb 
and the majority of non-PV triggers were mapped in the right 
atrium or coronary sinus.  Steinberg at al10 also found that in patients 
undergoing reablation for very late AF recurrence, just 4% of PVs 
were completely isolated. Conversely, Sotomi at al34 found that the 
prevalence of PV reconnections and trigger PV reconnection were 
significantly lower in the very late recurrence group (>12 months, 
69%) than in the late recurrence group (3-12 months, 90%) and also 
more patients required non-PV trigger ablation. In accordance with 
this observation, Kurotobi at al35 demonstrated that the presence of 
residual arrhytmogenic non-PV foci are associated with an increased 
long term recurrence rate after successful isolation of PVs and left 
atrial linear lesions in a long-standing persistent AF population. 
Conclusions
During the last decade, numerous data became available regarding 
the long term efficacy of the interventional treatment of atrial 
fibrillation. These data can be especially important for estimating 
prognosis, evaluation of currently available ablation techniques, 
and last but not least for the reimbursement policy of procedures. 
If we summarize the results of mostly retrospective analyses, we 
can conclude that long term freedom from AF is achievable and 
maintainable over 2-3 years or even more with mild increases in 
arrhythmia recurrence over the time. This statement is especially true 
for the paroxysmal AF population, following initial PVI procedures. 
Single procedure success rate is definitely lower in the long term, so 
for achieving a durable result, multiple procedures have to be taken 
into account. The success of an ablation procedure is less encouraging 
in the persistent population, moreover there is no real consensus 
regarding the best ablation strategy beyond PVI, to improve the long 
term efficacy rate.
It is likely that the main mechanism behind very late recurrences 
of AF is the PV reconduction and recurrent pulmonary vein triggers, 
but progressive remodeling of left atrial substrate as well as non-
PV triggers can play an important role over time, especially in the 
persistent AF population.
It should be noted that strict AF free success rates in both groups 
probably underestimate the real long term clinical benefit of the 
procedures if we focus on symptomatic improvement or fewer 
hospitalizations. Furthermore, it can not be overemphasized that 
studies demonstrating very different results regarding the outcome 
of procedures are showing significant heterogeneity in terms of the 
definition of success, methodology of follow up, and the applied 
ablation technologies.
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